Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.
The PIM family of serine/threonine kinases have become an attractive target for anti-cancer drug development, particularly for certain hematological malignancies. Here, we describe the discovery of a series of inhibitors of the PIM kinase family using a high throughput screening strategy. Through a...
Main Authors: | Bataille, C, Brennan, M, Byrne, S, Davies, S, Durbin, M, Fedorov, O, Huber, K, Jones, A, Knapp, S, Liu, G, Nadali, A, Quevedo, C, Russell, A, Walker, R, Westwood, R, Wynne, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2017
|
Similar Items
-
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
by: López-Ramos, M, et al.
Published: (2010) -
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
by: López-Ramos, M, et al.
Published: (2010) -
Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
by: Prudhomme Michelle, et al.
Published: (2010-10-01) -
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
by: Lopez-Ramos, M, et al.
Published: (2011) -
Structure and substrate specificity of the Pim-1 kinase
by: Bullock, A, et al.
Published: (2005)